Objective Capital retweeted
10 Articles from Our Contributors You Should Read from #2018: Life Sciences thought-leaders share their insider knowledge. pharmaboardroom.com/articles…
@rjsaynor @10habits @ObjectiveCap @BDPharmaExec @ThomasCueni @JanssenAP @methylogix @drmarkaware @chesterdavisjr @CarlaMSmith
Objective Capital retweeted
"In order to have a successful life sciences R&D program, biotech and pharma companies must develop game-changing therapeutics, companion diagnostics and personalized medicines." David Crean (@BDPharmaExec) MD @ObjectiveCap
pharmaboardroom.com/article/… …
Objective Capital retweeted
David Crean (@BDPharmaExec) Managing Director for @ObjectiveCap examines the venture investment activity in life sciences for 2018.
pharmaboardroom.com/article/…
#VentureCapital #lifesciences #biotech #biopharma
Objective Capital retweeted
Elevated Valuations Across the Board for #lifesciences in 2018
David H Crean (@BDPharmaExec), Managing Director for @ObjectiveCap, a leading investment banking advisory firm examines the #healthcare market for 2018.
pharmaboardroom.com/article/… …
Objective Capital retweeted
Thanks to the great coaches! Moderator:
Pamela Reeve
Judges:
Lesley Solomon @DanaFarber
David H. Crean, @ObjectiveCap and
Sarah MacDonald @LS_Cares – at Cambridge, MA
Objective Capital retweeted
Elevated Valuations Across the Board for #lifesciences in 2018
David H Crean (@BDPharmaExec), Managing Director for @ObjectiveCap, a leading investment banking advisory firm examines the #healthcare market for 2018.
pharmaboardroom.com/article/…
Objective Capital retweeted
The Health Care Hero Award for Company Executive - Finance goes to David Crean PhD @BDPharmaExec of Objective Capital @ObjectiveCap #Finance #SDBJ #HCHeroes2018







